Today’s guest blog comes from Anabela Cardoso, M.D., Lilly Immunology Global Brand Development Leader
Many patients, especially those with rheumatoid arthritis (RA), have complicated, individualized treatment plans to follow. Often times, these intricate treatment plans may result in disease management troubles for those living with autoimmune disease and chronic illness.
Recently Lilly partnered with CreakyJoints, a leading support, education, advocacy, and research organization for people living with arthritis and rheumatic disease, to better understand how the disease impacts patients’ everyday life.
As part of the study, CreakyJoints surveyed 258 patients and found that many have expressed dissatisfaction with their treatments. Patients with RA expressed living with their disease and coping with a chronic illness to be a challenge. In addition, they identified that more open lines of communication between patients and providers regarding the patients’ treatment experience and how their illness affects their daily life may lead to a better solution.
An increase in communication between doctors and patients can improve patients’ quality of life, and this study highlights how critical that communication can be for symptom management. By patients taking the time to explain their symptoms to their doctors, and the doctors listening intently, we can potentially see better disease management for those affected by RA.
We believe patients deserve the best quality of life while living with RA. This study has produced exciting information for us to better understand patient needs and how Lilly can help advocate for a stronger path towards desired disease management.